Fig. 4From: microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancerLow miR-193a-3p expression is associated with a worse survival of colorectal cancer patients treated with anti-EGFR therapy. Kaplan–Meyer curves for a OS from the start of anti-EGFR therapy and b PFS based upon the KRAS/BRAF mutational status (n = 45). Kaplan-Meyer curves for c OS and d PFS based upon miR-193a-3p expression in patients with any KRAS/BRAF mutational status (n = 45). Kaplan-Meyer curves for e OS and f PFS based upon miR-193a-3p expression in the KRAS/BRAF-wild-type group (n = 34)Back to article page